LAGE3 and melanoma: The results revealed that the expression of LAGE3 was elevated, compared with normal controls in breast cancer, colorectal cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma, melanoma, myeloma, and sarcoma respectively (Figure 1A).